ADVANCING
ORPHAN ONCOLOGY

TO IMPROVE THE LIFE OF PEOPLE
LIVING WITH CANCER
BY OFFERING BETTER TREATMENT OPTIONS

OUR STORY

Our Vision

Our vision is to be a leader in identifying, developing and commercializing novel drugs that address unmet needs of people with rare cancer conditions.

Learn more about us:

Ascelia Pharma company presentation May 2022

Q1-2022 investor conference call

Quarterly Report Q1-2022